Free shipping on all orders over $ 500

PRL 3195

Cat. No. M41940
PRL 3195 Structure
Size Price Availability Quantity
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

PRL 3195 is a somatostatin receptor antagonist with Kis of 6, 17, 66, 1000 and 1000 nM for human somatostatin receptors (sst5, sst2, sst3, sst1 and sst4, respectively).

Chemical Information
Molecular Weight 1177.83
Formula C58H69ClN12O9S2
CAS Number 341519-04-8
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Nolan Frey et al. Nat Commun. Microfluidics for understanding model organisms

Related Somatostatin Receptor Products
TT-232

TT-232 (CAP-232), a somatostatin derivative, is a peptide SSTR1/SSTR4 agonist.

Cyclosomatostatin

Cyclosomatostatin is a potent somatostatin (SST) receptor antagonist.

Somatostatin-28 (1-14)

Somatostatin-28 (1-14) is an N-terminal fragment of the neuropeptide somatostatin-28.

CH 275

CH 275 is a peptide analog of somatostatin and binds preferably to somatostatin receptor 1 (sst1) with a Ki of 52 nM.

CYN 154806

CYN 154806, a cyclic octapeptide, is a potent and selective somatostatin sst2 receptor antagonist.

  Catalog
Abmole Inhibitor Catalog




Keywords: PRL 3195 supplier, Somatostatin Receptor, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.